Yishen capsule promotes podocyte autophagy through regulating SIRT1/NF-κB signaling pathway to improve diabetic nephropathy

References

• Carney EF. Diabetic nephropathy: restoring podocyte proteostasis in DN. Nat Rev Nephrol. 2017;13(9):514.
   Web of Science ®Google Scholar
• Kume S, Koya D. Autophagy: a novel therapeutic target for diabetic nephropathy. Diabetes Metab J. 2015;39(6):451–460.
   PubMed Web of Science ®Google Scholar
• Kitada M, Ogura Y, Monno I, et al. Regulating autophagy as a therapeutic target for diabetic nephropathy. Curr Diab Rep. 2017;17(7):53.
   PubMed Web of Science ®Google Scholar
• Qin Q, Niu J, Wang Z, et al. Astragalus membranaceus inhibits inflammation via phospho-P38 mitogen-activated protein kinase (MAPK) and nuclear factor (NF)-κB pathways in advanced glycation end product-stimulated macrophages. Int J Mol Sci. 2012;13(7):8379–8387.
   PubMed Web of Science ®Google Scholar
• Yao XM, Liu YJ, Wang YM, et al. Astragaloside IV prevents high glucose-induced podocyte apoptosis via downregulation of TRPC6. Mol Med Rep. 2016;13(6):5149–5156.
   PubMed Web of Science ®Google Scholar
• Han LM, Fang JA, Sun YY, et al. Effect of citrus aurantium on the expression of SOCS-3 and IGF-1 in renal tissues of rats with diabetic nephropathy. Chin J Inter Trad Western Nephrol. 2014;9:767–769.
   Google Scholar
• Feng YL, Chen H, Tian T, et al. Diuretic and anti-diuretic activities of the ethanol and aqueous extracts of Alismatis rhizoma. J Ethnopharmacol. 2014;154(2):386–390.
   PubMed Web of Science ®Google Scholar
• Wojcikowski K, Wohlmuth H, Johnson DW, et al. An in vitro investigation of herbs traditionally used for kidney and urinary system disorders: potential therapeutic and toxic effects. Nephrology (Carlton). 2009;14(1):70–79.
   PubMed Web of Science ®Google Scholar
• Fang J, Deng A, Liu J. A clinical study of Yishen capsule in treating early diabetic nephropathy. Chin J Inter Trad Western Nephrol. 2005;6(8):457–459.
   Google Scholar
• Fang JA, Wei HK, Sun YY, et al. Regulation of podocalyxin expression in the kidney of streptozotocin-induced diabetic rats with Chinese herbs (Yishen capsule). BMC Complement Altern Med. 2013;13:76.
   PubMed Web of Science ®Google Scholar
• Zhang N, Fang JA, Sun YY, et al. Effect of Yishen capsule on nephrin, podocin of rats podocytes in high glucose. Chin J Inter Trad Western Nephrol. 2016;17(12):1077–1080.
   Google Scholar
• Kitada M, Kume S, Koya D. Role of sirtuins in kidney disease. Curr Opin Nephrol Hypertens. 2014;23(1):75–79.
   PubMed Web of Science ®Google Scholar
• Hong Q, Zhang L, Das B, et al. Increased podocyte Sirtuin-1 function attenuates diabetic kidney injury. Kidney Int. 2018;93(6):1330–1343.
   PubMed Web of Science ®Google Scholar
• Xie J, Zhang X, Zhang L. Negative regulation of inflammation by SIRT1. Pharmacol Res. 2013;67(1):60–67.
   PubMed Web of Science ®Google Scholar
• He ZJ, Zhu FY, Li SS, et al. Inhibiting ROS-NF-κB-dependent autophagy enhanced brazilin-induced apoptosis in head and neck squamous cell carcinoma. Food Chem Toxicol. 2017;101:55–66.
   PubMed Web of Science ®Google Scholar
• Behrends C, Sowa ME, Gygi SP, et al. Network organization of the human autophagy system. Nature. 2010;466(7302):68–76.
   PubMed Web of Science ®Google Scholar
• Tharaux PL, Huber TB. How is proteinuric diabetic nephropathy caused by disturbed proteostasis and autophagy in podocytes? Diabetes. 2016;65(3):539–541.
   PubMed Web of Science ®Google Scholar
• Liu N, Xu L, Shi Y, et al. Podocyte autophagy: a potential therapeutic target to prevent the progression of diabetic nephropathy. J Diabetes Res. 2017;2017:3560238.
   PubMed Web of Science ®Google Scholar
• Ma T, Zhu J, Chen X, et al. High glucose induces autophagy in podocytes. Exp Cell Res. 2013;319(6):779–789.
   PubMed Web of Science ®Google Scholar
• Jin Y, Liu S, Ma Q, et al. Berberine enhances the AMPK activation and autophagy and mitigates high glucose-induced apoptosis of mouse podocytes. Eur J Pharmacol. 2017;794:106–114.
   PubMed Web of Science ®Google Scholar
• Hou Y, Lin S, Qiu J, et al. NLRP3 inflammasome negatively regulates podocyte autophagy in diabetic nephropathy. Biochem Biophys Res Commun. 2020;521(3):791–798.
   PubMed Web of Science ®Google Scholar
• Tu Q, Li Y, Jin J, et al. Curcumin alleviates diabetic nephropathy via inhibiting podocyte mesenchymal transdifferentiation and inducing autophagy in rats and MPC5 cells. Pharm Biol. 2019;57(1):778–786.
   PubMed Web of Science ®Google Scholar
• Huang SS, Ding DF, Chen S, et al. Resveratrol protects podocytes against apoptosis via stimulation of autophagy in a mouse model of diabetic nephropathy. Sci Rep. 2017;7:45692.
   PubMed Web of Science ®Google Scholar
• Wang Y, Li Y, Zhang T, et al. Genistein and Myd88 activate autophagy in high glucose-induced renal podocytes in vitro. Med Sci Monit. 2018;24:4823–4831.
   PubMed Web of Science ®Google Scholar
• Kitada M, Kume S, Takeda-Watanabe A, et al. Sirtuins and renal diseases: relationship with aging and diabetic nephropathy. Clin Sci (Lond). 2013;124(3):153–164.
   PubMed Web of Science ®Google Scholar
• Kitada M, Kume S, Kanasaki K, et al. Sirtuins as possible drug targets in type 2 diabetes. Curr Drug Targets. 2013;14(6):622–636.
   PubMed Web of Science ®Google Scholar
• Howitz KT, Bitterman KJ, Cohen HY, et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature. 2003;425(6954):191–196.
   PubMed Web of Science ®Google Scholar
• Zhang XD, Fang JA, Li XX, et al. Effect of Yishen capsule on tubulointerstitial expression of TLR4 and NF-κB in experimental diabetic nephropathy. Chin J Kidney Dis Invest (Electronic Edition). 2013;2(4):28–31.
   Google Scholar
• Ding WJ, Fang JA, Sun YY, et al. Effect of Yishen Capsule on JAK/STAT signaling pathway α-SMA、FN expression in rats with diabetic nephropathy. Chin J Inter Trad Western Nephrol. 2013;14(6):484–487.
   Google Scholar
• Nakatani Y, Inagi R. Epigenetic regulation through SIRT1 in podocytes. Curr Hypertens Rev. 2016;12(2):89–94.
   PubMed Web of Science ®Google Scholar
• Kong L, Wu H, Zhou W, et al. Sirtuin 1: a target for kidney diseases. Mol Med. 2015;21:87–97.
   PubMed Web of Science ®Google Scholar
• Jieliang Shen JF, Hao J, Zhong X, et al. SIRT1 inhibits the catabolic effect of IL-1β through TLR2/SIRT1/NF-κB pathway in human degenerative nucleus pulposus cells. Pain Physician. 2016;19(1):E215–E226.
   PubMed Web of Science ®Google Scholar
• Pichler R, Afkarian M, Dieter BP, et al. Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets. Am J Physiol Renal Physiol. 2017;312(4):F716–F731.
   PubMed Web of Science ®Google Scholar
• Li S, Liu X, Lei J, et al. Crocin protects podocytes against oxidative stress and inflammation induced by high glucose through inhibition of NF-κB. Cell Physiol Biochem. 2017;42(4):1481–1492.
   PubMedGoogle Scholar
• Wu Y, Zhang Y, Wang L, et al. The role of autophagy in kidney inflammatory injury via the NF-κB route induced by LPS . Int J Med Sci. 2015;12(8):655–667.
   PubMed Web of Science ®Google Scholar
• Wei M, Li Z, Yang Z. Crosstalk between protective autophagy and NF-κB signal in high glucose-induced podocytes. Mol Cell Biochem. 2014;394(1-2):261–273.
   PubMed Web of Science ®Google Scholar